FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Joint Panel to Review Nektar Back Pain Drug

Federal Register notice: FDA announces a 1/14/2020 Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advis...

Federal Register

Review Period for Biomarins Palynziq

Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Biomarin Pharmaceuticals Palynziq (pegvaliase-p...

Human Drugs

Draft Guide on Corticosteroid Products for Hemorrhoids

FDA releases a draft guidance entitled Development of Locally Applied Corticosteroid Products for the Short-Term Treatment of Symptoms Associated with...

Medical Devices

Magnetic Resonance Coil Performance Criteria Guide

FDA posts a draft guidance on Magnetic Resonance (MR) Coil Performance Criteria for Safety and Performance Based Pathway.

Human Drugs

Amgens Remicade Biosimilar Gains Approval

FDA approves an Amgen BLA for Avsola (infliximab-axxq), a biosimilar of Janssens Remicade, indicated for treating Crohns disease, ulcerative colitis, ...

Biologics

Increased Enforcement on Violative Cell/Tissue Products

FDA steps up its enforcement efforts against violative cell/tissue products, and issues warnings against Liveyon Labs on the heels of similar actions ...

Human Drugs

Physician Convicted in Insy Therapeutics Scheme

A federal court convicts New York physician Gordon Freedman for participating in a scheme to receive bribes and kickbacks through sham educational pro...

Federal Register

2 Pain Drug NDAs Head to Panel

Federal Register notice: FDA announces a 1/15/2020 Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management A...

Human Drugs

FDA Seeking NDMA Testing

FDA asks manufacturers of Zantac and Axid to test for NDMA impurities and not release lots that are above the acceptable daily limit.

Federal Register

Dietary Supplement GMPs Info Collection

Federal Register notice: FDA is seeking comments on an information collection revision for Dietary Supplements good manufacturing practices.